Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.
Benzinga

Recap: Marinus Pharma Q1 Earnings

Marinus Pharma (NASDAQ:MRNS) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Marinus Pharma beat estimated earnings by 38.82%, reporting an EPS of $-0.52 versus an estimate of $-0.85.

Revenue was up $12.38 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 13.16% increase in the share price the next day.

To track all earnings releases for Marinus Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.